“A NOVEL RNA INTERFERENCE THERAPY TO REDUCE CARDIOVASCULAR RISK BY LOWERING LIPOPROTEIN(A) LEVELS USING THE LEPODISIRAN AGENT”. Journal of Multidisciplinary Sciences and Innovations 5, no. 03 (March 19, 2026): 1550–1553. Accessed March 20, 2026. https://ijmri.de/index.php/jmsi/article/view/6541.